Elixinol Global Ltd (E8M)
Market Closed
20 Dec, 20:00
XFRA 
€
0. 02
+0
+10%
€
- Market Cap
- P/E Ratio
0% Div Yield
2,999 Volume
- Eps
€ 0.02
Previous Close Day Range
0.02 0.02
Year Range
0 0.05
Want to track E8M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
E8M Chart
Elixinol Global Ltd Profile
| Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Ronald Dufficy BEC, FCPA CEO | XFRA Exchange | AU000000EXL4 ISIN |
| Australia Country | - Employees | - Last Dividend | 1 Dec 2024 Last Split | - IPO Date |
Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Contact Information
Address: 680 George Street
Phone: 61 2 8280 7355
Website: https://www.elixinolwellness.com
2024 © Marketlog. All Rights Reserved.
